Liver Surgery Unit, 3rd Department of Surgery, University School of Medicine, Humanitas Clinical Institute IRCCS, University of Milan, Via, Manzoni 56, Rozzano, 20089 Milan, Italy.
Updates Surg. 2010 Aug;62(1):21-6. doi: 10.1007/s13304-010-0004-0.
Since the efficiency of percutaneous ablation techniques in treating colorectal liver metastases is dependent on tumor size, the aim of this study was to verify the accuracy of computed tomography or magnetic resonance in estimating the maximum diameter of colorectal liver metastases by comparing these findings with those of pathology in a series of patients who underwent liver resection. Radiological and pathological tumor measurements in 39 patients operated for 69 colorectal liver metastasis were recorded. The radiological measurement was performed by magnetic resonance in 40 tumors (23 cases) and by computed tomography in 29 tumors (16 patients). The mean difference between pathological and radiological sizes was 0.4 cm (p < 0.001). Radiological size was smaller than pathological size in 60.9% of tumors, equal in 16% and bigger in 23% of tumors. The results indicated that radiology significantly underestimates the diameter of liver metastasis. To avoid on-site recurrence after percutaneous ablation therapies due to inaccurate radiological measurement, a radiological size of colorectal metastasis up to 2.5 cm should be considered as selection criteria for this treatment.
由于经皮消融技术治疗结直肠肝转移的疗效取决于肿瘤大小,因此本研究旨在通过比较经肝切除患者的病理结果,验证 CT 或 MRI 对结直肠肝转移最大直径的评估的准确性。对 39 例行肝切除术的 69 个结直肠肝转移瘤患者的影像学和病理肿瘤测量结果进行了记录。40 个肿瘤(23 例)行磁共振成像(MRI)检查,29 个肿瘤(16 例)行 CT 检查。病理和影像学大小的平均差值为 0.4cm(p<0.001)。60.9%的肿瘤影像学大小小于病理大小,16%的肿瘤两者相等,23%的肿瘤影像学大小大于病理大小。结果表明,影像学显著低估了肝转移瘤的直径。为了避免因不准确的影像学测量而导致经皮消融治疗后出现局部复发,对于该治疗方法,应将结直肠转移瘤的影像学直径达 2.5cm 作为选择标准。